Loading

Journal of Neurological Disorders and Stroke

The Cooperative Attempt of teLestroke-based Drip and ship Emergent Referral - the Aso (CALDERA) model

Research Article | Open Access

  • 1. Division of Neurology, Kumamoto Rousai Hospital, Yatsushiro, Japan
  • 2. Department of Neurosurgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
  • 3. Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
  • 4. Department of Neurology, Faculty of Medicine, Oita University, Oita, Japan
  • 5. Division of Medical Information Science and Administration Planning, Kumamoto, University Hospital, Kumamoto, Japan
  • 6. Division of Cerebrovascular Disease and Acute Coronary Syndrome, Kumamoto University Hospital, Kumamoto, Japan
+ Show More - Show Less
Corresponding Authors
Yutaka Kai, Department of Neurosurgery, Graduate School of Medical Sciences, Kumamoto University, 1-1-1, Honjo, Kumamoto, 860-8556, Japan, Tel: +81-96-373-5219, Fax: +81-96-371-8064;
ABSTRACT

In the Aso area of Kumamoto Prefecture in Japan there are no hospitals where stroke patients can receive acute-period revascularization treatments. As transfer to an out-of-area hospital takes approximately an hour, the interval between stroke onset and arrival at the distant care facility is long and of 11 patients transferred in 2010, only one received recombinant tissue plasminogen activator (rt-PA) therapy. Therefore, to make it possible to deliver rt-PA therapy at the primary emergency hospital we developed a telemedicine system that uses smartphones for communication between the out-of-area comprehensive stroke center and the primary emergency hospital. Patients with acute ischemic stroke are taken to the primary emergency hospital where the physician in charge uses the smartphone “RDICOM” application to upload the NIH stroke scale and a head CT image on a server. The stroke neurologist at the comprehensive stroke center then assesses the case and uses “RDICOM” information to make it possible to deliver rt-PA therapy at the primary hospital (“drip”). Patients requiring special treatment are transferred to a comprehensive stroke center (“ship”); during transfer rt-PA is delivered via intravenous drip infusion. Between June 2012 and August 2013, fourteen patients with acute ischemic stroke were taken to a primary emergency hospital in the Aso area. Of these, 6 underwent successful rt-PA therapy under the telemedicine-facilitated direction of an out-of-area stroke neurologist. At the time of admission, the mean NIH stroke scale of these 6 patients was 14.5. After rt-PA treatment it was 3.2. No patients suffered hemorrhagic complications. With the remote support provided by our smartphone telemedicine system it is possible to deliver rt-PA therapy even in areas where such treatment was formerly not possible.

CITATION

Honda S, Kai Y, Watanabe M, Hirano T, Usuku K, et al. (2014) The Cooperative Attempt of teLestroke-based Drip and ship Emergent Referral - the Aso (CALDERA) model. J Neurol Disord Stroke 2(2): 1046.

KEYWORDS

•    Ischemic stroke
•    Recombinant tissue plasminogen activator
•    Telemedicine
•    Telestroke
•    Drip & ship

ABBREVIATIONS

RT-PA: Recombinant Tissue Plasminogen Activator; Nih: National Institutes Of Health; Ct: Computed Tomography; Mrs: Modified Rankin Score; Mri; Magnetic Resonance Imaging; Mra; Magnetic Resonance Angiography; Caldera; Cooperative Attempt Of Telestroke-Based Drip And Ship Emergent Referral - The Aso

INTRODUCTION

In Japan, transvenous recombinant tissue plasminogen activator (rt-PA) therapy has been covered by medical insurance since October 2005. However, of stroke patients living in Japan only (2.5%) received rt-PA therapy in 2009 [1]. This may be attributable to the lack of stroke specialists at the admitting hospital or to the failure of patients to report to the nearest medical facility despite the presence of stroke symptoms.

The Aso medical district is located in northeastern of Kumamoto Prefecture in Japan. It is in an area surrounded by an outer rim of mountains that encloses highlands 400-800 meters above sea level. The population in Aso is approximately 70,000 and rt-PA treatment is not performed at local hospitals. Most acute stroke patients are taken 40 km by ambulance to a secondary emergency hospital near Kumamoto City; the transportation time is approximately one hour. During 2010, of 35 patients with suspected acute stroke, 11 suffered acute cerebral infarcts and were transported to undergo rt-PA therapy at secondary hospitals within 3 hours from onset. However, only one patient arrived in time to receive rt-PA treatment. In the other 10 the interval between stroke onset and their arrival at the secondary hospital was too long for effective rt-PA therapy.

This indicated that a new system for the administration of immediate drip rt-PA therapy at local primary emergency hospitals was needed in this geographic area (“drip”). Then these patients can be transported (“shipped”) to a comprehensive stroke center for the completion of rt-PA treatment. We designate this method the “drip and ship” system and its system was called Cooperative Attempt of teLestroke-based Drip and ship Emergent Referral - the Aso (CALDERA) (Figure 1). The Aso area had the most famous CALDERA in the world.

 

MATERIALS AND METHODS

Our case in point is a patient who was transported to the local primary emergency hospital (Aso Central Hospital) within 3 hours of stroke onset (4.5 hours since September 2012). At the time of admission a blood test and neurological examinations were performed to determine the NIH stroke scale. Then chest X-ray- and head CT studies were performed and the images were uploaded on the server. Simultaneously, a stroke specialist at the comprehensive stroke center of Kumamoto University Hospital was contacted by smartphone to determine whether the patient should be transferred for further neurological examinations. The stroke specialist referred to the CT images provided by the “RDICOM” smartphone application to determine whether there were early ischemic changes or other abnormal findings and submitted a preliminary assessment. With the iPhone 4S smartphone it was possible to connect to Wi-Fi via the primary hospital’s wireless LAN system and data were available via a 3G circuit. The system, produced by TRIART Co. (Fukuoka, Japan), also transferred the NIH stroke scale.

To rule out contraindications for the administration of rt-PA, the patient’s eligibility for thrombolytic therapy is established at the primary hospital. For additional treatment at Kumamoto University Hospital, weather permitting, the patient is transferred by helicopter; in bad weather or at night transportation is by ambulance. If no improvements are seen by the time the patient arrives at Kumamoto University Hospital, an MRI scan is acquired to determine the appropriateness of thrombectomy using Merci or Penumbra systems. In the absence of large hyperintensity areas on diffusion-weighted images and the existence of a mismatch between diffusion- and perfusion-weighted images thrombectomy is performed within 8 hours after stroke onset.

RESULTS

CALDERA was started in June 2012. By August 2013, 19 patients (10 males, 9 females, age range 40 - 93 years) suspected of having suffered a stroke within the preceding 3 hours (4.5 hours since September 2012) were admitted to Aso Central Hospital (Table 1). The diagnosis at the time of local admission was cerebral hemorrhage in 5 and cerebral infarction in 14 patients. The NIH stroke scale in the 19 patients ranged from 1 - 29 (mean 10.0). In these patients, six patients received rt-PA treatment. The NIH stroke scale in the 6 patients ranged from 6 - 29 (mean 14.5). Between 5 - 42 min (mean 20.3 min) elapsed between their admission at Aso Central Hospital and the acquisition of CT studies. As the interval between CT and rt-PA delivery was 20 - 119 min.

The NIH stroke scale was 3 - 12 (mean 6.2) 24 hours after rt-PA administration; at the time of discharge it ranged from 0 - 9 (mean 3.2). The modified Rankin score (mRS) 3 months after rt-PA treatment was 0 - 1 in 3 cases, 3 in one case, and 4 - 5 in 2 cases (Table 2).

CASE PRESENTATION

A 40-year-old female Aso resident (case 12 in Table 1, case 4 in Table 2) sustained a fall in her kitchen at 06:45. She was admitted to a local hospital where a CT scan showed no bleeding. She was drowsy and manifested global aphasia and complete right hemiparesis. At 09:40 she arrived by ambulance at Aso Central Hospital without a change in her right paralysis and aphasia. A CT scan showed no early CT signs (Figure 2) and an Edaravone drip was started. Her NIH stroke scale was 20. As rt-PA delivery was not contraindicated it was started at 10:05 (3 hr 20 min after her fall).

With a physician on board she was transported by helicopter to Kumamoto University Hospital where she arrived at 11:21. Although her right paralysis was improved, her speech disturbance was not and her NIH stroke scale was 11. Diffusion-weighted MRI showed a small hyperintensity area in the left insular cortex. Magnetic resonance angiography (MRA) yielded a poor image of the left middle cerebral artery branches (Figure 3). Therefore additional interventional treatment targeting the left middle cerebral artery branches was delivered with the aid of a Penumbra system. Post-treatment angiography showed complete recanalization of the left middle cerebral artery branches at 13:47 (7 hr 2 min after onset) (Figure 4). After 24 hr her speech disturbance disappeared and her NIH stroke scale was 8; at discharge it was 1 and her mRS was 1 three months later.

Table 1: Summary of 19 patients suspected of having suffered a stroke within the preceding 3 hours (4.5 hours since September 2012) were admitted to Aso Central Hospital.

Case No. Age Sex NIH Stroke Score Diagnosis Rt-PA
1 89 M 11 cerebral infarction +
2 84 F 15 cerebral hemorrhage -
3 93 M 12 cerebral infarction +
4 83 M 4 cerebral hemorrhage -
5 79 M 1 cerebral infarction -
6 74 F 6 cerebral hemorrhage -
7 74 M 1 cerebral infarction -
8 85 F 9 cerebral hemorrhage -
9 72 M 3 cerebral infarction -
10 87 F 6 cerebral infarction +
11 41 F 23 cerebral hemorrhage -
12 40 F 20 cerebral infarction +
13 89 F 22 cerebral infarction -
14 68 M 1 cerebral infarction -
15 80 F 9 cerebral infarction +
16 77 M 29 cerebral infarction +
17 92 F 6 cerebral infarction -
18 71 M 9 cerebral infarction -
19 79 M 3 cerebral infarction -

NIH: National Institutes of Health.

Table 2: Summary of six patients received rt-PA treatment.

Case No. Age Sex attack – treatment (min) ASPECTS NIH stroke score mRS (at 3 months after)
Attack-Admission (min) Admission ~ CT (min) CT ~ treatment (min) admission ~ Treatment (min) On admission After 24 hours At discharge
1 89 F 175 10 11 6 3 4
122 18 35 53  
2 93 M 87 10 12 12 9 5
35 17 35 52  
3 87 F 133 10 6 4 0 0
77 25 31 56  
4 40 F 200 7 20 8 1 1
175 5 20 25  
5 80 F 194 10 9 4 5 3
33 42 119 161  
6 77 M 101 10 29 3 1 1
60 15 26 41  

 

DISCUSSION

In Japan, the administration of intravenous rt-PA therapy within 3 hours of acute ischemic stroke onset has been approved since 2005. However, relatively few patients have received rt-PA treatment. In September 2012, the approved interval between the occurrence of acute cerebral infarction and rt-PA delivery was extended to 4.5 hours. Although the patient age and possible contraindications must be considered, we expect an increase in the number of patients who would benefit from rt-PA treatment. In rural areas there are few facilities that can deliver this therapy because specialist in treating acute stroke patients tend to congregate in urban areas. Consequently, to help acute stroke patients living in remote areas, an information-technology-based system that facilitates a remote diagnosis is needed.

The usefulness, reliability, and safety of telemedicine systems have been investigated [2-8] (Table 3) and the ability to transfer DICOM images for viewing on monitors is highly valuable. However, such systems require large capital investments and they tend to be cumbersome. As our system uses a smartphone to view the images and a server for the fast and easy uploading of images, it can be implemented at a relatively low cost. Even when an acute stroke specialist is not available at the stroke center, contact can be made via the smartphone.

The usefulness of remotely-performed stroke examinations with the aid of smartphones and the FaceTime application installed on iPhone 4 has been reported [9,10]. These instruments facilitate the transfer of the NIH stroke scale and of CT images to specialists at the comprehensive stroke center and allow the oral and visual presentation of patient data and of the patient’s condition by non-specialists at the primary emergency hospital.

The “drip and ship” approach to treat patients with acute stroke has been evaluated in the literature [11-13]. We found that the interval between our patients’ arrival at the emergency hospital and the inception of rt-PA administration was approximately 64.7 minutes. This complies with the international guidelines of the American Heart Association [14]. Although our study population was small, none of our patients presented with symptomatic intracranial hemorrhage and 3 of 6 patients manifested a mRS score below 2 three months after suffering the insult.

Table 3: Comparison of telemedicine systems for stroke.

  Hub/Spoke Data transfer System Cost
TEMPiS 2/12 Picture transfer Videoconference -
REACH 1/8 DICOM data transfer Television + video camera + microphone 10000 dollar
TESS 1/7 DICOM data transfer Television + video camera + microphone 8000 dollar
STARR 1/2 - Television + video camera + microphone -
STRokE DOC 1/4 DICOM data transfer Television + video camera + microphone -
CALDERA 1/1 iPhone 4S (RDICOM) iPhone 4S (Face Time) 2500 dollar

TEMPiS: Telemedical Project for Integrative Stroke Care, REACH: 
Remote Evaluation for Acute Ischemic Stroke, TESS: Telemedicine 
in Stroke in Swabia, STARR: Stroke Telemedicine for Arizona Rural 
Residents, STROKE DOC: Stroke Team Remote Evaluation Using a Digital 
Observation Camera, CALDERA: Cooperative Attempt of teLestroke-based Drip and ship Emergent Referral - the Aso.

Table 4: Comparison of telemedicine systems for treatment of RT-PA.

  Martin-Schild et. al Pervez et. al Lazaridis et. al CALDERA
Age (mean) 65 73.6 68 77.7
Man percentage 44 42.9 47.8 33.3
Case number 84 84 185 6
attack – treatment (min) 150 140 152 148.3
attack-admission (min) 65 - 60 83.7
admission-treatment (min) 85 - 90 64.7
NIH stroke scale        
On admission 10.7 13 10 14.5
After 24 hours - - - 6.8
At discharge - - - 3.2
additional IVR treatment(%) 6 0 0 16.7
mRS (3 months after) (%) 30 - - 50
symptomatic intracranial hematoma (%) 6 4.8 1.6 0

NIH: National Institutes of Health, mRS: modified Rankin scale, CALDERA: Cooperative Attempt of telestroke-based Drip and ship Emergent Referral - the Aso.

CONCLUSION

The “drip and ship” method to deliver rt-PA treatment to patients with remotely-diagnosed acute stroke is of great value, especially with reference to patients living in remote areas without stroke specialists. Advances in information technology render this method scalable and may eliminate regional differences in the administration t-PA therapy to stroke patients.

REFERENCES

1. Nakagawara J, Minematsu K, Okada Y, Tanahashi N, Nagahiro S, Mori E, et al. Thrombolysis with 0.6 mg/kg intravenous alteplase for acute ischemic stroke in routine clinical practice: the Japan post-Marketing Alteplase Registration Study (J-MARS). Stroke. 2010; 41: 1984-1989.

2. Demaerschalk BM, Miley ML, Kiernan TE, Bobrow BJ, Corday DA, Wellik KE, et al. Stroke telemedicine. Mayo Clin Proc. 2009; 84: 53-64.

3. Audebert HJ, Kukla C, Clarmann von Claranau S, Kühn J, Vatankhah B, Schenkel J, et al. Telemedicine for safe and extended use of thrombolysis in stroke: the Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria. Stroke. 2005; 36: 287-291.

4. Wang S, Lee SB, Pardue C, Ramsingh D, Waller J, Gross H, et al. Remote evaluation of acute ischemic stroke: reliability of National Institutes of Health Stroke Scale via telestroke. Stroke. 2003; 34: e188-191.

5. Wang S, Gross H, Lee SB, Pardue C, Waller J, Nichols FT 3rd, et al. Remote evaluation of acute ischemic stroke in rural community hospitals in Georgia. Stroke. 2004; 35: 1763-1768.

6. Wiborg A, Widder B; Telemedicine in Stroke in Swabia Project. Teleneurology to improve stroke care in rural areas: The Telemedicine in Stroke in Swabia (TESS) Project. Stroke. 2003; 34: 2951-2956.

7. Demaerschalk BM, Miley ML, Kiernan TE, Bobrow BJ, Corday DA, Wellik KE, et al. Stroke telemedicine. Mayo Clin Proc. 2009; 84: 53-64.

8. Meyer BC, Lyden PD, Al-Khoury L, Cheng Y, Raman R, Fellman R, et al. Prospective reliability of the STROKE DOC wireless/site independent telemedicine system. Neurology. 2005; 64: 1058-1060.

9. Anderson ER, Smith B, Ido M, Frankel M. Remote assessment of stroke using the iPhone 4. J Stroke Cerebrovasc Dis. 2013; 22: 340-344.

10. Demaerschalk BM, Vegunta S, Vargas BB, Wu Q, Channer DD, Hentz JG. Reliability of real-time video smartphone for assessing National Institutes of Health Stroke Scale scores in acute stroke patients. Stroke. 2012; 43: 3271-3277.

11. Martin-Schild S, Morales MM, Khaja AM, Barreto AD, Hallevi H, Abraham A, et al. Is the drip-and-ship approach to delivering thrombolysis for acute ischemic stroke safe? J Emerg Med. 2011; 41: 135-141.

12. Pervez MA, Silva G, Masrur S, Betensky RA, Furie KL, Hidalgo R, et al. Remote supervision of IV-tPA for acute ischemic stroke by telemedicine or telephone before transfer to a regional stroke center is feasible and safe. Stroke. 2010; 41: e18-24.

13. Lazaridis C, DeSantis SM, Jauch EC, Adams RJ. Telestroke in South Carolina. J Stroke Cerebrovasc Dis. 2013; 22: 946-950.

14. Jauch EC, Cucchiara B, Adeoye O, Meurer W, Brice J, Chan YY, et al. Part 11: adult stroke: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010; 122: S818-828.

Honda S, Kai Y, Watanabe M, Hirano T, Usuku K, et al. (2014) The Cooperative Attempt of teLestroke-based Drip and ship Emergent Referral - the Aso (CALDERA) model. J Neurol Disord Stroke 2(2): 1046.

Received : 25 Dec 2013
Accepted : 27 Jan 2014
Published : 29 Jan 2014
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X